Amicus Therapeutics (FOLD)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 09-2019 | 06-2019 | 03-2019 | 12-2018 | 09-2018 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -266,659 | -204,850 | -120,299 | -348,995 | -270,914 |
| Depreciation Amortization | 5,551 | 4,249 | 2,640 | 15,192 | 10,883 |
| Accounts receivable | -12,644 | -6,829 | -1,001 | -13,294 | -5,182 |
| Other Working Capital | -8,803 | -2,126 | -11,462 | -4,727 | -6,334 |
| Other Operating Activity | 89,971 | 72,525 | 51,576 | 51,869 | 32,269 |
| Operating Cash Flow | $-192,584 | $-137,031 | $-78,546 | $-299,955 | $-239,278 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | 77,277 | 70,107 | 83,009 | -114,892 | -52,828 |
| PPE Investments | -9,087 | -5,110 | -2,944 | -6,308 | -4,571 |
| Investing Cash Flow | $68,190 | $64,997 | $80,065 | $-121,200 | $-57,399 |
| Cash Flows From Financing Activities | |||||
| Debt Issued | N/A | N/A | N/A | 146,596 | 146,622 |
| Debt Repayment | -177 | -98 | -75 | -334 | -218 |
| Common Stock Issued | 197,614 | 196,566 | 4,765 | 307,345 | 306,693 |
| Common Stock Repurchased | -3,001 | -2,555 | -1,938 | -2,832 | -2,681 |
| Other Financing Activity | 19,875 | 19,875 | 14,632 | 0 | 0 |
| Financing Cash Flow | $214,311 | $213,788 | $17,384 | $450,775 | $450,416 |
| Exchange Rate Effect | -2,591 | -941 | -2,350 | 1,518 | -1,146 |
| Beginning Cash Position | 82,375 | 82,375 | 82,375 | 51,237 | 51,237 |
| End Cash Position | 169,701 | 223,188 | 98,928 | 82,375 | 203,830 |
| Net Cash Flow | $87,326 | $140,813 | $16,553 | $31,138 | $152,593 |
| Free Cash Flow | |||||
| Operating Cash Flow | -192,584 | -137,031 | -78,546 | -299,955 | -239,278 |
| Capital Expenditure | -9,087 | -5,110 | -2,944 | -6,308 | -4,571 |
| Free Cash Flow | -201,671 | -142,141 | -81,490 | -306,263 | -243,849 |